?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener
Filter & Suche
518 Ergebnisse (1 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
518 Unternehmen gefunden • Seite 14 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Newron Pharmaceuticals SpA | 29.3 | Arzneimittel (Biotechnologie) | Italien | 0.3 Mrd. USD | - | 7.66 | 12.80 | -22.01 | ▲ 29.47% | ▼ -8.81% | - | - | - | -69.22% | ▲ 69.67% | -24.56% | ▲ 64.90% | 169.99% | ▲ 88.59% | 3 / 9 | −4,49 | 1-fach | 48 / 100 | −114,4 / 100 | −8,52 |
 | Cytokinetics Inc | 29.2 | Arzneimittel (Biotechnologie) | USA | 10.3 Mrd. USD | - | - | 144.53 | -59.12 | ▲ 9.54% | ▲ 43.88% | - | - | - | -891.60% | ▼ -395.17% | -695.44% | ▼ -342.18% | -607.48% | ▼ -250.69% | 5 / 9 | −8,23 | −6,7-fach | 5 / 100 | −19,3 / 100 | −3,30 |
| Yifan Xinfu Pharmaceutical Co Ltd | 29.0 | Arzneimittel (Pharmazeutisch) | China | 1.7 Mrd. USD | 36.89 | - | 2.25 | 1.26 | ▼ -1.01% | ▼ -16.12% | 1.09% | ▲ 14.87% | - | 7.83% | ▲ 0.55% | 11.25% | ▲ 1.65% | -1.97% | ▲ 1.04% | 6 / 9 | 4,13 | 1-fach | 19 / 100 | −0,4 / 100 | −2,93 |
 | Twist Bioscience Corp | 28.9 | Arzneimittel (Biotechnologie) | USA | 8.4 Mrd. USD | - | - | 19.53 | 18.92 | ▲ 33.11% | ▼ -11.11% | - | - | - | -20.63% | ▲ 22.90% | -36.18% | ▲ 21.02% | -20.08% | ▲ 25.94% | 5 / 9 | −2,10 | −14.369,1-fach | 30 / 100 | −4,7 / 100 | −2,14 |
 | Roivant Sciences Ltd | 28.8 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 29.5 Mrd. USD | - | - | 3914.66 | 6.97 | ▼ -19.07% | ▼ -18.01% | - | - | - | -3629.19% | ▼ -159.23% | -15560.57% | ▼ -2800.50% | -9183.51% | ▼ -1604.23% | 2 / 9 | 16,68 | > 50-fach | 0 / 100 | 9,1 / 100 | - |
 | Arbutus Biopharma Corp | 28.7 | Arzneimittel (Biotechnologie) | USA | 1.0 Mrd. USD | 6.63 | - | 5.58 | 3.92 | ▲ 15.29% | ▼ -12.07% | - | - | - | -237.88% | ▼ -4.30% | -192.08% | ▼ -11.49% | -281.45% | ▼ -28.09% | 4 / 9 | −39,33 | −253,4-fach | 14 / 100 | 6,5 / 100 | 0,28 |
| Aktis Oncology, Inc. Common stock | 28.6 | Arzneimittel (Biotechnologie) | USA | 1.3 Mrd. USD | - | - | 128.82 | 2.67 | ▲ 35.11% | ▲ 15.59% | - | - | - | -980.93% | ▲ 3.24% | -1149.52% | ▼ -182.52% | -1134.54% | ▲ 249.85% | 3 / 9 | 1,01 | −26,4-fach | 2 / 100 | 0,2 / 100 | −0,20 |
| ADICON Holdings Ltd | 28.4 | Arzneimittel (Biotechnologie) | China | 0.4 Mrd. USD | 133.20 | - | 0.93 | 1.43 | ▼ -0.77% | ▼ -42.13% | - | - | - | 0.70% | ▼ -2.97% | 3.81% | ▼ -3.16% | 4.45% | ▼ -2.36% | 5 / 9 | 2,04 | 4-fach | 20 / 100 | −4,4 / 100 | −2,59 |
| Zhejiang Starry Pharm Co Ltd | 28.4 | Arzneimittel (Pharmazeutisch) | China | 0.5 Mrd. USD | 172.05 | - | 1.47 | 1.46 | ▲ 12.34% | ▼ -46.74% | 3.31% | ▲ 1.88% | - | 0.42% | ▼ -3.01% | 5.60% | ▼ -2.84% | -10.86% | ▼ -2.86% | 6 / 9 | 0,84 | 1-fach | 8 / 100 | 0,1 / 100 | −2,52 |
 | CG Oncology, Inc. Common stock | 28.4 | Arzneimittel (Biotechnologie) | USA | 6.4 Mrd. USD | - | - | 1029.73 | 6.23 | - | - | - | - | - | -3985.02% | ▲ 310.49% | -4722.13% | ▼ -81.47% | -3279.21% | ▲ 238.74% | 4 / 9 | 23,38 | −42,1-fach | −0 / 100 | −3,6 / 100 | 2,50 |
 | Dianthus Therapeutics Inc. | 28.2 | Arzneimittel (Biotechnologie) | USA | 5.8 Mrd. USD | - | - | 3049.14 | 4.95 | - | - | - | - | - | -7973.33% | ▼ -1508.94% | -8739.34% | ▼ -1687.63% | -6349.36% | ▼ -526.13% | 3 / 9 | 14,36 | - | 0 / 100 | −6,3 / 100 | −4,59 |
 | Perrigo Company PLC | 28.1 | Arzneimittel (Pharmazeutisch) | Irland | 1.9 Mrd. USD | - | 10.80 | 0.46 | 0.75 | ▲ 0.79% | ▲ 54.37% | 8.49% | ▲ 3.86% | 22 Jahre | -33.51% | ▼ -6.45% | 8.07% | ▼ -0.29% | 3.41% | ▲ 0.75% | 5 / 9 | −0,38 | −1,7-fach | 18 / 100 | −19,5 / 100 | −3,74 |
 | Xenon Pharmaceuticals Inc | 28.1 | Arzneimittel (Biotechnologie) | Kanada | 5.7 Mrd. USD | - | - | 567.06 | 8.07 | ▲ 89.00% | ▲ 62.31% | - | - | - | -4612.13% | ▼ -928.92% | -4974.27% | ▼ -996.61% | -3732.23% | ▼ -820.87% | 2 / 9 | −1,50 | −83,2-fach | 1 / 100 | −6,8 / 100 | −2,04 |
| Green Cross Corp | 28.0 | Arzneimittel (Biotechnologie) | Südkorea | 1.0 Mrd. USD | - | 26.02 | 0.75 | 1.18 | ▲ 5.77% | - | 1.17% | - | - | -0.23% | ▼ -2.19% | 3.47% | ▼ -0.55% | -0.29% | ▼ -1.08% | 6 / 9 | 2,30 | 0-fach | 20 / 100 | −3,7 / 100 | −2,73 |
 | Ideaya Biosciences Inc | 27.9 | Arzneimittel (Biotechnologie) | USA | 3.6 Mrd. USD | - | - | 15.49 | 3.03 | ▲ 62.11% | ▲ 28.65% | - | - | - | -51.99% | ▼ -357.72% | -72.84% | ▼ -433.42% | -33.59% | ▼ -306.31% | 4 / 9 | 13,17 | −22,3-fach | −9 / 100 | −3,8 / 100 | 13,72 |
 | Immunitybio Inc | 27.8 | Arzneimittel (Biotechnologie) | USA | 8.4 Mrd. USD | - | - | 50.57 | -8.01 | ▲ 184.76% | ▲ 22.18% | - | - | - | -310.18% | ▲ 24440.35% | -226.00% | ▲ 21431.17% | -272.56% | ▲ 23590.01% | 4 / 9 | −24,62 | −2,5-fach | 22 / 100 | −9,3 / 100 | 4,30 |
 | Insmed Inc | 27.8 | Arzneimittel (Biotechnologie) | USA | 28.3 Mrd. USD | - | - | 24.84 | 37.31 | ▲ 29.83% | ▲ 34.13% | - | - | - | -210.54% | ▼ -1.48% | -194.04% | ▼ -4.51% | -159.55% | ▲ 4.73% | 5 / 9 | −7,29 | −10,7-fach | 21 / 100 | −15,1 / 100 | −2,16 |
 | Axsome Therapeutics Inc | 27.6 | Arzneimittel (Pharmazeutisch) | USA | 11.6 Mrd. USD | - | - | 14.89 | 138.81 | - | - | - | - | - | -28.69% | ▲ 319.92% | -26.51% | ▲ 306.15% | -14.70% | ▲ 263.26% | 5 / 9 | −5,75 | −35,2-fach | 86 / 100 | −13,0 / 100 | −2,65 |
 | Aclaris Therapeutics Inc | 27.5 | Arzneimittel (Pharmazeutisch) | USA | 0.8 Mrd. USD | - | - | 95.28 | 6.29 | ▲ 3.84% | ▲ 4.94% | - | - | - | -829.58% | ▲ 61.54% | -975.91% | ▲ 24.61% | -603.42% | ▲ 46.57% | 4 / 9 | −15,48 | - | 4 / 100 | −11,1 / 100 | 4,20 |
 | Iovance Biotherapeutics Inc | 27.5 | Arzneimittel (Biotechnologie) | USA | 3.9 Mrd. USD | - | - | 11.99 | 5.29 | - | - | - | - | - | -148.38% | - | -153.08% | - | -127.61% | - | 5 / 9 | −7,20 | - | 28 / 100 | −9,7 / 100 | −3,21 |
 | Editas Medicine Inc | 27.3 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 8.82 | 3.94 | ▼ -14.89% | ▲ 7.91% | - | - | - | -395.01% | ▲ 96.23% | -245.15% | ▲ 139.10% | -409.30% | ▲ 76.89% | 4 / 9 | −29,69 | −64,8-fach | 22 / 100 | 2,8 / 100 | −5,52 |
| Chongqing Pharscin Pharmaceutical Co Ltd | 27.3 | Arzneimittel (Pharmazeutisch) | China | 0.8 Mrd. USD | 73.64 | - | 6.83 | 3.14 | ▼ -1.29% | ▼ -11.40% | 0.57% | - | - | 7.87% | ▼ -0.86% | 8.42% | ▼ -0.93% | 5.76% | ▲ 3.02% | 6 / 9 | 9,77 | > 50-fach | 24 / 100 | 0,1 / 100 | −3,19 |
 | Ocular Therapeutix Inc | 27.3 | Arzneimittel (Pharmazeutisch) | USA | 2.3 Mrd. USD | - | - | 44.26 | 4.43 | ▲ 24.39% | ▲ 11.31% | - | - | - | -513.17% | ▼ -116.19% | -521.04% | ▼ -80.03% | -418.53% | ▼ -62.07% | 4 / 9 | 3,62 | −13,7-fach | 6 / 100 | −7,6 / 100 | −2,92 |
 | Arcus Biosciences Inc | 27.1 | Arzneimittel (Biotechnologie) | USA | 3.1 Mrd. USD | - | - | 26.76 | 6.75 | ▲ 25.93% | ▲ 23.50% | - | - | - | -142.91% | ▼ -18.48% | -156.28% | ▼ -21.87% | -195.95% | ▼ -69.84% | 1 / 9 | −0,51 | −65,9-fach | 21 / 100 | 11,3 / 100 | −2,26 |
 | Nektar Therapeutics | 27.1 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | - | - | 43.63 | 2.64 | ▼ -18.43% | ▼ -18.07% | - | - | - | -297.07% | ▲ 71.30% | -236.77% | ▲ 55.61% | -377.83% | ▲ 24.00% | 3 / 9 | −41,55 | −6,0-fach | 20 / 100 | 15,9 / 100 | −1,69 |
